Diffuse large b-cell lymphoma refractory: Which Medications Cause It? (832 Reports Across 70 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Diffuse large b-cell lymphoma refractory has been reported as an adverse event with 70 different drugs in the FDA's FAERS database, with 832 total reports. 254 of these reports resulted in death.The drugs most commonly associated with Diffuse large b-cell lymphoma refractory are RITUXIMAB, CYCLOPHOSPHAMIDE, and DOXORUBICIN.
832
Total Reports
70
Drugs Involved
254
Deaths
140
Hospitalizations
62.9 yrs
Average Patient Age
45.9% / 54.1%
Female / Male
Which Drugs Cause Diffuse large b-cell lymphoma refractory Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| RITUXIMAB | 461 | 0.3% | 63 | 77 | 12 |
| CYCLOPHOSPHAMIDE | 360 | 0.3% | 52 | 61 | 19 |
| DOXORUBICIN | 345 | 0.4% | 37 | 62 | 7 |
| VINCRISTINE | 331 | 0.5% | 36 | 51 | 7 |
| ETOPOSIDE | 244 | 0.5% | 40 | 68 | 16 |
| PREDNISONE | 214 | 0.1% | 23 | 36 | 2 |
| EPCORITAMAB-BYSP | 198 | 20.3% | 101 | 25 | 7 |
| CYTARABINE | 193 | 0.4% | 32 | 50 | 19 |
| DEXAMETHASONE | 170 | 0.1% | 27 | 20 | 8 |
| CISPLATIN | 156 | 0.3% | 25 | 42 | 6 |
| IFOSFAMIDE | 154 | 0.9% | 25 | 9 | 4 |
| PREDNISOLONE | 127 | 0.2% | 17 | 20 | 5 |
| GEMCITABINE | 124 | 0.4% | 22 | 23 | 13 |
| CARBOPLATIN | 114 | 0.1% | 18 | 8 | 4 |
| METHOTREXATE | 85 | 0.0% | 6 | 6 | 7 |
| OXALIPLATIN | 79 | 0.1% | 15 | 13 | 11 |
| POLATUZUMAB VEDOTIN | 65 | 1.4% | 8 | 3 | 0 |
| BENDAMUSTINE | 61 | 0.3% | 7 | 2 | 0 |
| LENALIDOMIDE | 60 | 0.0% | 27 | 1 | 0 |
| SELINEXOR | 51 | 0.7% | 13 | 8 | 0 |